TITLE

Reassortment between Amantadine- Resistant and -Sensitive H1N1 Influenza A Viruses Generated an Amantadine-Sensitive Virus during the 2007—2008 Season

AUTHOR(S)
Furuse, Yuki; Suzuki, Akira; Shimizu, Midori; Kishi, Makiko; Sawayama, Rumi; Saito, Mariko; Fuji, Naoko; Nukiwa, Nao; Oshitani, Hitoshi
PUB. DATE
December 2009
SOURCE
Journal of Infectious Diseases;12/1/2009, Vol. 200 Issue 11, p1766
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The frequency of the amantadine-resistant H1N1 influenza A virus has been increasing since the 2005-2006 season. It is unclear whether reassortment was involved in this trend. Here, we show that cocirculation of amantadine-resistant and -sensitive strains led to the genesis of amantadine-sensitive reassortant virus during the 2007-2008 season. Thereafter, the reassortant virus predominated. This contrasts with the trend for the H3N2 virus, in which the amantadine-resistant reassortant virus became predominant. The results suggest that it is necessary to monitor genome dynamics to understand the evolution and mechanism of the emergence and spread of antiviral resistance among influenza A viruses.
ACCESSION #
45566203

 

Related Articles

  • Swine Flu (H1N1) update 2010. Amerena, Vincent C. // eLABORATE;Jan/Feb2010, p116 

    The article provides updated information through January 1, 2010 on the H1N1 influenza. The virus is transmitted from human to human, and countries are no longer required to report cases to the World Health Organization (WHO). Antiviral drug resistance, water contamination of the drug ostelamvir...

  • 2009H1N1 Influenza in Immunocompetent and Immunocompromised Patients. Moss, Ronald B. // Infectious Diseases: Research & Treatment;2012, Issue 5, p33 

    The treatment and prevention of influenza virus infection has been associated with two major challenges that are exemplified by 2009H1N1 as well as previous pandemics. The constant evolutionary pressure on the influenza virus can result in novel strains which may not be optimally protected by...

  • H1N1 2009 Pandemic Influenza Virus: Resistance of the I223R Neuraminidase Mutant Explained by Kinetic and Structural Analysis. Van Der Vries, Erhard; Collins, Patrick J.; Vachieri, Sebastien G.; Xiaoli Xiong; Junfeng Liu; Walker, Philip A.; Haire, Lesley F.; Hay, Alan J.; Schutten, Martin; Osterhaus, Albert D. M. E.; Martin, Steve R.; Boucher, Charles A. B.; Skehel, John J.; Gamblin, Steve J. // PLoS Pathogens;Sep2012, Vol. 8 Issue 9, Special section p1 

    Two classes of antiviral drugs, neuraminidase inhibitors and adamantanes, are approved for prophylaxis and therapy against influenza virus infections. A major concern is that antiviral resistant viruses emerge and spread in the human population. The 2009 pandemic H1N1 virus is already resistant...

  • Drug resistant swine flu emerges.  // New Scientist;7/4/2009, Vol. 203 Issue 2715, p6 

    The article focuses on the first case of H1N1 swine flu resistant to antiviral drug Tamiflu. The patient was in contact with an infected person and was given low-dose Tamiflu as a precaution, but she still developed flu. Such patient recovered after receiving antiviral Relenza. The author notes...

  • H1N1 Update: Lessons learned, implications for 2010. Bunch, Debbie // AARC Times;Jan2010, Vol. 34 Issue 1, p28 

    The article reports on recent developments regarding the H1N1 influenza pandemic. It states that a report from the Centers for Disease Control and Prevention (CDC) says that flu activity in the U.S. is declining, but the virus is still spreading elsewhere around the world, especially in eastern...

  • Simultaneous Detection of Oseltamivir- and Amantadine-Resistant Influenza by Oligonucleotide Microarray Visualization. Zhang, Yingjie; Liu, Qiqi; Wang, Dou; Chen, Suhong; Wang, Shengqi // PLoS ONE;Feb2013, Vol. 8 Issue 2, p1 

    Presently, the resistance of Influenza A virus isolates causes great difficulty for the prevention and treatment of influenza A virus infection. It is important to establish a drug-resistance detection method for epidemiological study and personalized medicine in the clinical setting....

  • Conferinte.  // Romanian Journal of Infectious Diseases;2012, Vol. 15 Issue 3, p142 

    No abstract available.

  • Editorial Commentary: What Did We Learn From the Emergency Use Authorization of Peramivir in 2009? Pavia, Andrew T. // Clinical Infectious Diseases;Jul2012, Vol. 55 Issue 1, p16 

    The author reflects on the consequences of the pandemics caused by Influenza A (H1N1) virus in 2009 for the patients resistant to the available antiviral drugs and has raised the issue of growing crisis in pharmaceutical development. The reason for this crisis may be due to the leniency of...

  • Respiratory Tract Infections Caused by New Influenza A (H1N1). Gad, Niveen M.; Abu-Zahab, Zakia; Zakzouk, Zeinab // Australian Journal of Basic & Applied Sciences;2010, Vol. 4 Issue 6, p1055 

    Novel influenza A (H1N1) virus is the pathogen of recent global outbreaks of febrile respiratory infection. Objective: was to describe baseline characteristics, treatment, and outcomes of the majority of patients with confirmed 2009 influenza A (H1N1). Subjects and methods: nasopharyngeal swab...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics